Pharma

Your Article Summary

See Latest Articles

Biopure Receives Notice of Nasdaq Delisting
BioPure, 07/01/09

Biopure Corporation announced that it has received notice from The Nasdaq Stock Market, by letter dated June, 2009, that it is out of compliance with the Nasdaq Marketplace Rules and its common stock may be delisted. The notice stated that the company no longer meets the minimum of $2,500,000 in stockholders' equity for continued listing on the Nasdaq Capital Market.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09

Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09

New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09

See All of Regulatory Issues